NIRBA is Singapore’s strategic national effort to build globally leading capabilities in RNA biology, driving innovation and applications that address critical health challenges. Supported by the National Research Foundation (NRF) and partner institutions, National University of Singapore (NUS), Nanyang Technological University (NTU), and Agency for Science, Technology and Research (A*STAR), NIRBA is poised to transform Singapore into a global hub for RNA research and its wide-ranging applications to further our understanding of RNA biology, create advancements in research and innovative applications.
To create differentiated, globally competitive peaks of excellence for research on RNA Biology & its Applications, poised to fuel downstream translation and health impact.
Swiftly establish leading foundational research peaks in RNA biology, particularly in understanding RNA’s role in diseases prevalent in Asian populations.
Develop an agile model through dynamic, multidisciplinary “Innovation Clusters” that bring together top scientists to create and sustain competitive research peaks in RNA biology.
Build innovative pathways to generate a research pipeline to fuel national programmes such as NATi (Nucleic Acid Therapeutics initiative), RNA Foundry, PREPARE, and PRECISE, driving economic growth through innovation.
NIRBA is a collaborative effort involving multiple stakeholders in Singapore. Together, these institutions power the core of NIRBA’s research, spanning the four Innovation Clusters. NIRBA’s work is deeply integrated with national biomedical and translational platforms, enabling real-world impact through aligned programmes.